Ming Zhou

Title: The Innovations of Ming Zhou

Introduction

Ming Zhou is a notable inventor based in Shandong, China. He has made significant contributions to the field of biotherapeutics, particularly through his work on recombinant fusion proteins. With a total of 2 patents, his innovations are paving the way for advancements in medical treatments.

Latest Patents

Ming Zhou's latest patents focus on the development of human neuregulin-1 (NRG-1) recombinant fusion protein compositions. These inventions relate to a recombinant fusion protein that comprises a fragment of the cardioprotective protein neuregulin-1 (NRG-1) fused to a monoclonal antibody (mAb) backbone. The methods of use for these compositions involve treating diseases or conditions in subjects by administering a therapeutically effective amount of the recombinant fusion protein or the pharmaceutical composition that includes it.

Career Highlights

Throughout his career, Ming Zhou has worked with prominent companies in the biotherapeutics sector. Notable among these are Salubris Biotherapeutics, Inc. and Salubris (Chengdu) Biotech Co., Ltd. His work in these organizations has contributed to the advancement of innovative medical solutions.

Collaborations

Ming Zhou has collaborated with esteemed colleagues, including John H Li and Shengwei Li. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapeutic solutions.

Conclusion

Ming Zhou's contributions to the field of biotherapeutics through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical treatments, showcasing the importance of innovation in healthcare.